International Stem Cell CORP SEC filings ISCO
International Stem Cell CORP has 825 filings in SEC EDGAR's recent list, going back to Apr 4, 2006. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 8, 2026 (acquisition or sale of assets). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14C | Information statement | Aug 4, 2026 | Aug 4, 2026 |
| PRE 14C | Preliminary information statement | Jul 24, 2026 | Jul 24, 2026 |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 11, 2026 |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 17, 2025 |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 11, 2024 |
| DEF 14C | Information statement | Sep 27, 2023 | Sep 27, 2023 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 14, 2023 |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 9, 2022 |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 9, 2021 |
| DEF 14A | Proxy statement | Jun 2, 2020 | Jun 23, 2020 |
| DEF 14A | Proxy statement | Apr 30, 2019 | Jun 3, 2019 |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 21, 2018 |
| DEF 14A | Proxy statement | Apr 28, 2017 | May 31, 2017 |
| DEF 14A | Proxy statement | Apr 18, 2016 | May 13, 2016 |
| PRE 14A | Preliminary proxy statement | Apr 7, 2016 | May 13, 2016 |
| DEF 14A | Proxy statement | Mar 31, 2015 | May 7, 2015 |
| DEFA14A | Additional proxy material | Nov 3, 2014 | — |
| DEF 14A | Proxy statement | Oct 29, 2014 | Dec 4, 2014 |
| PRE 14A | Preliminary proxy statement | Oct 17, 2014 | Dec 4, 2014 |
| DEFA14A | Additional proxy material | Mar 25, 2014 | — |
| DEF 14A | Proxy statement | Mar 25, 2014 | May 8, 2014 |
| PRE 14A | Preliminary proxy statement | Mar 12, 2014 | May 8, 2014 |
| DEFA14A | Additional proxy material | Apr 30, 2013 | — |
| DEF 14A | Proxy statement | Apr 30, 2013 | Jun 10, 2013 |
| DEFA14A | Additional proxy material | Apr 17, 2012 | — |
| DEF 14A | Proxy statement | Apr 16, 2012 | May 29, 2012 |
| PRE 14A | Preliminary proxy statement | Apr 6, 2012 | May 29, 2012 |
| DEF 14A | Proxy statement | Mar 30, 2011 | May 3, 2011 |
| DEF 14A | Proxy statement | Mar 30, 2010 | Apr 28, 2010 |
| DEF 14A | Proxy statement | Mar 30, 2009 | Apr 30, 2009 |
| DEF 14A | Proxy statement | Mar 21, 2008 | Mar 21, 2008 |
| DEF 14C | Information statement | Jan 9, 2007 | Jan 10, 2006 |
| PRE 14C | Preliminary information statement | Dec 29, 2006 | Jan 10, 2006 |
Showing 33 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ISCO (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1355790
- Former names
- BTHC III INC. (until Jan 19, 2007)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.